Showing results (971-980 of 995) with videos related to

Sort By:
Pageof 100
Journal of Pharmaceutical Policy and Practice|July 5, 2023
Delivering the precision oncology paradigm: reduced R&D costs and greater return on investment through a companion diagnostic informed precision oncology medicines approachRaymond H Henderson, Declan French, Elaine Stewart, et al.
Journal of Pharmaceutical Policy and Practice|August 7, 2023
Acute coronary syndrome and its treatment outcomes in Ethiopia: a systematic review and meta-analysisBekalu Kebede, Melese Getachew, Samuel Agegnew, et al.
Journal of Pharmaceutical Policy and Practice|September 28, 2023
Pipeline progress and portfolio management of the top 30 pharma companies over the past two decadesMelanie Büssgen, Marcel A Büssgen
Journal of Pharmaceutical Policy and Practice|September 28, 2023
Assessment of public knowledge and attitude toward antibiotics use and resistance: a community pharmacy-based surveyAbdulmuminu Isah, Azeez Babatunde Aina, Kenechukwu C Ben-Umeh, et al.
Journal of Pharmaceutical Policy and Practice|June 8, 2023
Determinants of adverse reactions to first-line antitubercular medicines: a prospective cohort studyRichard Delali Agbeko Djochie, Berko Panyin Anto, Mercy Naa Aduele Opare-Addo
Journal of Pharmaceutical Policy and Practice|September 22, 2023
Impact of COVID-19 on the supply chain of essential health commodities: a mixed method study, in Dar es Salaam, TanzaniaPius Ipagala, Eulambius M Mlugu, Rogers Mwakalukwa, et al.
Journal of Pharmaceutical Policy and Practice|October 3, 2023
General practitioners' perceptions of the roles of community pharmacists and their willingness to collaborate with pharmacists in primary careJoy Boon Ka Chong, Clivia Yao Hua Yap, Shawn Lien Ler Tan, et al.
Journal of Pharmaceutical Policy and Practice|March 5, 2026
Real-world effectiveness, safety, and quality of life of biosynthetic semaglutide in Pakistani adults with type 2 diabetes mellitus: a study protocolMuhammad Daoud Butt, Arshad Hussain, Siew Chin Ong
Journal of Pharmaceutical Policy and Practice|April 15, 2026
The registration status of maternal, newborn, and child health medical products: evidence from 9 countriesJane Briggs, Kate Kikule, Helena Walkowiak, et al.
Pageof 100